Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model

An exosome linked to RAGE-binding-peptide was developed as a hypoxia-specific carrier for nose-to-brain delivery of anti-microRNA oligonucleotide for ischemic stroke therapy.